Dermata Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $7.5M | $3.2M | $7.4M | $6.2M | $10.8M | $530.4K |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | — | — | — | — | $11.6M | $605.5K |
| Property, Plant & Equipment | — | — | — | — | $0 | $0 |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $7.9M | $3.5M | $8.0M | $6.9M | $11.6M | $605.5K |
| Liabilities | ||||||
| Accounts Payable | $460.8K | $808.0K | $866.0K | $496.7K | $515.2K | $104.3K |
| Total Current Liabilities | — | — | — | — | $1.5M | $3.8M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $1.6M | $2.0M | $1.6M | $922.6K | $1.5M | $3.8M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-73.2M | $-65.7M | $-53.4M | $-45.6M | $-36.0M | $-28.1M |
| Total Stockholders' Equity | $6.2M | $1.6M | $6.4M | $6.0M | $10.1M | $-3.2M |